Minsk Municipal Clinical Hospital 5
About Minsk Municipal Clinical Hospital 5
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Celgene
3
Polpharma Biologics S.A.
1
RVL Pharmaceuticals, Inc.
1
Clinical Trials at Minsk Municipal Clinical Hospital 5
During the past decade, Minsk Municipal Clinical Hospital 5 conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis
2013-12-03
2017-04-13
Completed
1,320
Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)
2014-12-03
2016-12-22
Completed
1,346
A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis
2015-10-16
2023-01-05
Completed
2,350
A Study to Investigate the Safety and Effectiveness of Arbaclofen Extended-Release Tablets for Patients With MS
2018-01-28
2019-01-02
Completed
536
Efficacy and Safety of the Biosimilar Natalizumab PB006 in Comparison to Tysabri®
2019-10-01
2022-02-07
Completed
265
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Minsk Municipal Clinical Hospital 5"
#1 collaborator was "Osmotica Pharmaceutical US LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Minsk Municipal Clinical Hospital 5
According to Clinical.Site data, the most researched conditions in "Minsk Municipal Clinical Hospital 5" are
"Multiple Sclerosis" (3 trials), "Relapsing Multiple Sclerosis" (1 trials), "Relapsing-Remitting Multiple Sclerosis (RRMS)" (1 trials) and "Spasticity, Muscle" (1 trials). Many other conditions were trialed in "Minsk Municipal Clinical Hospital 5" in a lesser frequency.
Clinical Trials Intervention Types at Minsk Municipal Clinical Hospital 5
Most popular intervention types in "Minsk Municipal Clinical Hospital 5" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Interferon beta-1a" (2 trials), "Ozanimod" (2 trials), "Arbaclofen" (1 trials), "Interferon beta-1a placebo" (1 trials) and "Intravenous (IV) infusions" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Minsk Municipal Clinical Hospital 5
The vast majority of trials in "Minsk Municipal Clinical Hospital 5" are
5 trials for "All" genders.
Clinical Trials Status at Minsk Municipal Clinical Hospital 5
Currently, there are NaN active trials in "Minsk Municipal Clinical Hospital 5".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Minsk Municipal Clinical Hospital 5,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Minsk Municipal Clinical Hospital 5, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".